Y Intercept Hong Kong Ltd Buys Shares of 47,491 Arteris, Inc. (NASDAQ:AIP)

Y Intercept Hong Kong Ltd purchased a new stake in Arteris, Inc. (NASDAQ:AIP - Free Report) during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 47,491 shares of the company's stock, valued at approximately $328,000. Y Intercept Hong Kong Ltd owned approximately 0.11% of Arteris at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. Quarry LP bought a new position in Arteris in the 4th quarter valued at about $46,000. CWM LLC grew its position in Arteris by 4,810.1% in the 1st quarter. CWM LLC now owns 10,213 shares of the company's stock valued at $71,000 after buying an additional 10,005 shares in the last quarter. Cambridge Investment Research Advisors Inc. bought a new position in Arteris in the 1st quarter valued at about $95,000. D. E. Shaw & Co. Inc. bought a new position in Arteris in the 4th quarter valued at about $110,000. Finally, Price T Rowe Associates Inc. MD bought a new position in Arteris in the 4th quarter valued at about $117,000. 64.36% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In other Arteris news, CFO Nicholas B. Hawkins sold 11,000 shares of the stock in a transaction that occurred on Thursday, May 8th. The stock was sold at an average price of $7.54, for a total transaction of $82,940.00. Following the transaction, the chief financial officer owned 165,596 shares in the company, valued at $1,248,593.84. This trade represents a 6.23% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Saiyed Atiq Raza sold 29,544 shares of the stock in a transaction that occurred on Tuesday, July 29th. The shares were sold at an average price of $10.07, for a total value of $297,508.08. Following the completion of the sale, the director directly owned 653,118 shares of the company's stock, valued at $6,576,898.26. This represents a 4.33% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 158,366 shares of company stock worth $1,492,653. Insiders own 29.10% of the company's stock.

Wall Street Analyst Weigh In

Separately, Rosenblatt Securities reiterated a "buy" rating and issued a $14.00 target price on shares of Arteris in a research report on Wednesday, May 21st.

Arteris Stock Performance

Shares of NASDAQ AIP traded down $0.81 during mid-day trading on Friday, reaching $9.05. The company had a trading volume of 487,288 shares, compared to its average volume of 326,059. The stock has a fifty day moving average of $8.85 and a two-hundred day moving average of $8.43. The company has a market capitalization of $379.92 million, a price-to-earnings ratio of -11.04 and a beta of 1.44. Arteris, Inc. has a 12-month low of $5.46 and a 12-month high of $12.64.

Arteris Company Profile

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.